For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $32.42 in the prior trading day, Agios Pharmaceuticals Inc (NASDAQ: AGIO) closed at $33.23, up 2.50%. In other words, the price has increased by $2.50 from its previous closing price. On the day, 0.56 million shares were traded. AGIO stock price reached its highest trading level at $33.5 during the session, while it also had its lowest trading level at $32.4.
Ratios:
Our goal is to gain a better understanding of AGIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.77 and its Current Ratio is at 8.99. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Leerink Partners Downgraded its Outperform to Market Perform on September 27, 2024, whereas the target price for the stock was revised from $60 to $56.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’25 when Milanova Tsveta sold 2,804 shares for $32.18 per share. The transaction valued at 90,233 led to the insider holds 18,906 shares of the business.
Milanova Tsveta bought 2,804 shares of AGIO for $89,279 on Jan 03 ’25. On Dec 11 ’24, another insider, Scadden David, who serves as the Director of the company, sold 200 shares for $46.28 each. As a result, the insider received 9,256 and left with 15,483 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 1895113472 and an Enterprise Value of 951190400. As of this moment, Agios’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.65 while its Price-to-Book (P/B) ratio in mrq is 1.16. Its current Enterprise Value per Revenue stands at 28.937 whereas that against EBITDA is -2.37.
Stock Price History:
The Beta on a monthly basis for AGIO is 0.87, which has changed by 0.50720596 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, AGIO has reached a high of $62.58, while it has fallen to a 52-week low of $20.96. The 50-Day Moving Average of the stock is -26.91%, while the 200-Day Moving Average is calculated to be -21.83%.
Shares Statistics:
The stock has traded on average 875.57K shares per day over the past 3-months and 1034030 shares per day over the last 10 days, according to various share statistics. A total of 57.02M shares are outstanding, with a floating share count of 55.13M. Insiders hold about 3.33% of the company’s shares, while institutions hold 104.73% stake in the company. Shares short for AGIO as of 1735603200 were 5526130 with a Short Ratio of 6.31, compared to 1732838400 on 4573782. Therefore, it implies a Short% of Shares Outstanding of 5526130 and a Short% of Float of 9.83.